Join
Live feed
·
INSIDERFilingvia Quantisnow
Mereo BioPharma Group plc logo

Chief Scientific Officer Lewicki John A. converted options into 69,000 units of American Depositary Shares representing Ordinary Shares, increasing direct ownership by 1,724% to 73,003 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MREO (Mereo BioPharma Group plc) and more on Quantisnow.

Chief Scientific Officer Lewicki John A. converted options into 69,000 units of American Depositary Shares representing Ordinary Shares, increasing direct ownership by 1,724% to 73,003 units (SEC Form 4) | Quantisnow